How Tariffs Could Disrupt Health Care—And What States Can Do About It

Health Affairs October 2, 2025
Geeta Minocha

Editor’s Note

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance Administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.

Nowhere are the risks of disruption from the Trump administration’s tariffs more acute than in the pharmaceutical and medical device sectors. The United States is heavily dependent on imported active pharmaceutical ingredients (APIs), particularly from China and the EU. China, subject to a...

Today's Sponsors

Today's Sponsor